Missling is putting into place the Licensing Dream Team..
I think we are going after Adjunctive Patent.. so other people don't mimic our drug and put it with another drug trying to skirt our Rights.. IMO The good Dr is trying to create a massive right not just for different indications but as A2-73 being the Ultimate Adjunct.
Like lets say another drug may stimulate Neironal Cell growth but it has a hard time activating growth with out creating downstream counter measures.. Now if the Chaperone is involved you have so much help.. You have Homeostasis, and as the cell growth stimulant acts.. the Chaperone may act to regulate success..so many drugs will work better with the A2-72 ChaperoneIMO..